STX17 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.993000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.095800E-01
Normal-vs-Stage2
2.859200E-01
Normal-vs-Stage3
4.390100E-02
Normal-vs-Stage4
8.436800E-01
Stage1-vs-Stage2
6.617800E-01
Stage1-vs-Stage3
5.993800E-02
Stage1-vs-Stage4
7.417600E-01
Stage2-vs-Stage3
1.27975408048542E-12
Stage2-vs-Stage4
3.645200E-01
Stage3-vs-Stage4
7.687700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.949800E-01
Normal-vs-AfricanAmerican
5.753200E-01
Normal-vs-Asian
3.540400E-01
Caucasian-vs-AfricanAmerican
6.667600E-01
Caucasian-vs-Asian
9.061600E-01
AfricanAmerican-vs-Asian
7.876000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.798400E-01
Normal-vs-Female
3.333200E-01
Male-vs-Female
7.701800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.631820E-01
Normal-vs-Age(41-60Yrs)
6.590400E-01
Normal-vs-Age(61-80Yrs)
1.789960E-01
Normal-vs-Age(81-100Yrs)
1.925190E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.800800E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.309200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.959600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.579000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.914200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.937600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.049970E-01
Normal-vs-Daily Drinker
2.386800E-01
Normal-vs-Weekly Drinker
2.853200E-01
Normal-vs-Occasional Drinker
3.478200E-01
Normal-vs-Social Drinker
8.635600E-01
Non Drinker-vs-Daily Drinker
6.458800E-01
Non Drinker-vs-Weekly Drinker
8.039000E-01
Non Drinker-vs-Occasional Drinker
3.330000E-01
Non Drinker-vs-Social Drinker
1.860120E-02
Daily Drinker-vs-Weekly Drinker
9.074400E-01
Daily Drinker-vs-Occasional Drinker
6.474200E-01
Daily Drinker-vs-Social Drinker
8.869600E-02
Weekly Drinker-vs-Occasional Drinker
6.219600E-01
Weekly Drinker-vs-Social Drinker
1.284960E-01
Occasional Drinker-vs-Social Drinker
2.132000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.131800E-02
Normal-vs-Grade 2
1.150100E-02
Normal-vs-Grade 3
5.283200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.106000E-01
Grade 1-vs-Grade 3
2.738000E-01
Grade 1-vs-Grade 4
5.131800E-02
Grade 2-vs-Grade 3
2.835000E-01
Grade 2-vs-Grade 4
1.150100E-02
Grade 3-vs-Grade 4
5.283200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.068040E-01
Normal-vs-NonDiabetic
2.951600E-01
Diabetic-vs-NonDiabetic
1.755600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.928000E-01
Normal-vs-NoPancreatitis
2.385600E-01
Pancreatitis-vs-NoPancreatitis
5.672600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.741400E-01
Normal-vs-N1
2.784600E-01
N0-vs-N1
9.385600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.070600E-01
Normal-vs-TP53-NonMutant
6.490000E-01
TP53-Mutant-vs-TP53-NonMutant
6.382200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
